Authors:
Engelfriet, CP
Reesink, HW
Pietersz, RNI
Schwartz, DWM
Mayr, WR
Blajchman, MA
Goldman, M
Decary, F
Sher, G
Georgsen, J
Sprogoe-Jakobsen, U
Kekomaki, R
Kuhnl, P
Seitz, R
Maniatis, A
Pinter, J
Baroti, K
Shinar, E
Rebulla, P
Greppi, N
Sirchia, G
Faber, JC
Flanagan, P
Brand, A
Letowska, M
Nel, T
Argelagues, E
Martin-Vega, C
AuBuchon, JP
Williamson, L
Wallington, T
Citation: Cp. Engelfriet et al., Universal leucocyte-depletion of blood components: cell concentrates and plasma, VOX SANGUIN, 81(1), 2001, pp. 56-77
Citation: Br. Jackson et al., The cost-effectiveness of postoperative recovery of RBCs in preventing transfusion-associated virus transmission after joint arthroplasty, TRANSFUSION, 40(9), 2000, pp. 1063-1066
Authors:
Thurer, RL
Luban, NLC
AuBuchon, JP
Silver, H
McCarthy, LJ
Dzik, S
Stowell, CP
Moore, SB
Vamvakas, EC
Armstrong, W
Kanter, MH
Jeter, E
Becker, J
Higgins, M
Galel, S
Kleinman, S
Marshall, CS
Newman, R
Ocariz, JA
Blackall, D
Petz, LD
Toy, P
Oberman, H
Siegel, DL
Price, TH
Slichter, SJ
Gernsheimer, T
Mintz, P
Goodnough, LT
Lipford, EH
Simpson, MB
Citation: Rl. Thurer et al., Universal WBC reduction, TRANSFUSION, 40(6), 2000, pp. 751-752
Authors:
Kruskall, MS
AuBuchon, JP
Anthony, KY
Herschel, L
Pickard, C
Biehl, R
Horowitz, M
Brambilla, DJ
Popovsky, MA
Citation: Ms. Kruskall et al., Transfusion to blood group A and O patients of group B RBCs that have beenenzymatically converted to group O, TRANSFUSION, 40(11), 2000, pp. 1290-1298
Citation: Jp. Aubuchon, Public health, public trust, and public decision making: making hepatitis C virus lookback work, TRANSFUSION, 39(2), 1999, pp. 123-127
Authors:
Goodnough, LT
Brecher, ME
Kanter, MH
AuBuchon, JP
Citation: Lt. Goodnough et al., Medical progress - Transfusion medicine - Second of two parts - Blood conservation, N ENG J MED, 340(7), 1999, pp. 525-533
Authors:
Goodnough, LT
Brecher, ME
Kanter, MH
AuBuchon, JP
Citation: Lt. Goodnough et al., Medical progress - Transfusion medicine (First of two parts) - Blood transfusion, N ENG J MED, 340(6), 1999, pp. 438-447
Authors:
Fratantoni, JC
Sibinga, CTS
Spence, RK
Murphy, W
van Aken, WG
Laupacis, A
de Wolf, JTM
AuBuchon, JP
Lust, A
de Wit, HJC
Tahhan, HR
van Heukelom, LHS
Valeri, CR
Citation: Jc. Fratantoni et al., The clinical setting: How to optimise supportive haemotherapy - Discussion, DEV HEMATOL, 33, 1998, pp. 43-52
Authors:
Valeri, CR
de Wit, HJC
Sibinga, CTS
de Vries, EGE
AuBuchon, JP
Winslow, RM
Boralessa, H
Fratantoni, JC
Middleton, S
de Leij, L
Goodnough, LT
Nicolson, DM
Lust, A
Citation: Cr. Valeri et al., Chemical and biological alternatives - Discussion, DEV HEMATOL, 33, 1998, pp. 123-131
Citation: Jp. Aubuchon, Cost-effectiveness of conventional and alternative approaches in transfusion practice: The value of decision analysis, DEV HEMATOL, 33, 1998, pp. 215-221